Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples